SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.25 HKD | -1.13% |
|
-2.42% | -9.17% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED is a China-based company principally engaged in the development, production and distribution of chemical bulk drugs, preparations and medical intermediates. The Companyâs main products include metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, L-dopa, pipemidic acid tablets, compound liquorice tablets and nimodipine tablets. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and others.
Sector
Pharmaceuticals
Calendar
2024-04-24
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -9.17% | 1.17B | |
| +25.27% | 672B | |
| +24.08% | 550B | |
| -6.30% | 351B | |
| +15.04% | 317B | |
| +7.19% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -10.26% | 144B | |
| -7.30% | 141B |
- Stock Market
- Equities
- 719 Stock
- News Shandong Xinhua Pharmaceutical Company Limited
- Chinese Regulator Clears Xinhua Pharma's $40 Million Funding Deal with Parent; Shares Fall 4%
